Navidea Biopharmaceuticals Inc (NAVB)
0.035
0.00 (0.00%)
USD |
OTCM |
Apr 19, 15:21
Navidea Biopharmaceuticals Cash from Investing (TTM): -0.7011M for Sept. 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -0.7011M |
June 30, 2023 | -0.2554M |
March 31, 2023 | -0.3116M |
December 31, 2022 | -0.3903M |
September 30, 2022 | -0.4077M |
June 30, 2022 | -0.462M |
March 31, 2022 | -0.3801M |
December 31, 2021 | -0.3294M |
September 30, 2021 | -0.3226M |
June 30, 2021 | -0.3959M |
March 31, 2021 | -0.4159M |
December 31, 2020 | -0.4128M |
September 30, 2020 | -0.3882M |
June 30, 2020 | 0.0199M |
March 31, 2020 | 0.4791M |
December 31, 2019 | 0.7704M |
September 30, 2019 | 0.8015M |
June 30, 2019 | 0.5838M |
March 31, 2019 | 0.7807M |
December 31, 2018 | 0.9538M |
September 30, 2018 | 1.178M |
June 30, 2018 | 1.171M |
March 31, 2018 | -1.434M |
December 31, 2017 | -1.834M |
September 30, 2017 | -2.031M |
Date | Value |
---|---|
June 30, 2017 | -2.008M |
March 31, 2017 | -0.0374M |
December 31, 2016 | -0.0392M |
September 30, 2016 | -0.0478M |
June 30, 2016 | -0.0497M |
March 31, 2016 | -0.0443M |
December 31, 2015 | -0.0278M |
September 30, 2015 | -0.0476M |
June 30, 2015 | -0.4198M |
March 31, 2015 | -0.5177M |
December 31, 2014 | -1.525M |
September 30, 2014 | -1.998M |
June 30, 2014 | -1.726M |
March 31, 2014 | -1.928M |
December 31, 2013 | -1.292M |
September 30, 2013 | -0.8393M |
June 30, 2013 | -0.9827M |
March 31, 2013 | -0.8873M |
December 31, 2012 | -0.6718M |
September 30, 2012 | -0.5566M |
June 30, 2012 | 26.86M |
March 31, 2012 | 27.08M |
December 31, 2011 | 27.16M |
September 30, 2011 | 27.06M |
June 30, 2011 | -0.2162M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.7011M
Minimum
Sep 2023
0.8015M
Maximum
Sep 2019
-0.1399M
Average
-0.3548M
Median
Cash from Investing (TTM) Benchmarks
Perspective Therapeutics Inc | 24.37M |
Electromed Inc | -1.219M |
Xtant Medical Holdings Inc | -24.78M |
Asensus Surgical Inc | 64.51M |
Senseonics Holdings Inc | 89.71M |